Posted on 05/02/2022 3:39:50 PM PDT by SeekAndFind
The U.S. could soon have a new COVID vaccine on the market but this one will be different from the others.
Novavax asked the Food and Drug Administration to authorize its COVID-19 vaccine for adults in late-January and that application remains under review, but the company recently released data surrounding a new trial that could target both flu and COVID at the same time.
So what exactly is Novavax and what should you know about the vaccine? Here's a breakdown.
For certain groups of people — particularly young men — the mRNA vaccines carry a slightly elevated risk of a heart condition called myocarditis. Novavax's vaccine has not been linked to myocarditis.
But in addition, the company is also in clinical trials of a version of its vaccine that would target both COVID and flu at the same time. The company said its first phase of the trial showed the potential for triggering an antibody response to both viruses, though further study is needed. A second phase of the trial is set to begin "by the end of 2022."
"We continue to evaluate the dynamic public health landscape and believe there may be a need for recurrent boosters to fight both COVID-19 and seasonal influenza," Dr. Gregory M. Glenn, president of research and development for Novavax, said in a statement. "
(Excerpt) Read more at msn.com ...
Still was tested on dead babies. No thanks.
Not taking it. Will wait for 10 to 15 year safety studies. It’s insane many people, including employed in the medical field, will inject something into their blood - into their blood, when the risk is so incredibly low for most.
Gimme, gimme, gimme
Made from old stockpiles of novachek
Well tell you in 75 years. Nothing to worry about, we’re liability free.
Still not interested, but thanks for sharing.
It still focuses on the spike protein [sticks the protein directly into you] and is not the same as naturally acquired immunity.
Because it would be immediately made available, the FDA will never authorize it because it would instantly cause the repeal of the EUA for the Pfizer and Moderna vaccines. While those drugs have been approved by the FDA, they were not being made available in the United States, resulting in their EUA's being constantly renewed.
An approved and available Novovax drug would kill the market dominance of the Pfizer and Moderna drugs. It would force those companies to swiftly make their drugs available in the United States, which I doubt they're ready to do.
-PJ
Sounds like this one is safe and effective!
Bump
I’ll await my “news” from a source with real reporters. Yes, they are rare, and few if any have toy journalism degrees.
You gotta ask yourself, why isn’t Comirnaty available in the US? Having a population of over 300,000,000 ppl makes America an extremely lucrative market, and yet they’d rather use it on third world countries and overseas, which makes no sense. That leads me to conclude that, despite what Pfizer, the media, and our govt. says, testing is NOT over and the vaccine still hasn’t been officially approved. Sounds like we were right all along. 🤬
As long as they are still lying about ivermectin and hydroxy and lying about vax injuries, I see no reason to believe them about anything else.
Anyway, it’s still a flu with a 99% recovery rate. I’ve never had a flu shot. I see no reason to start now.
I believe it's only being made available in third world countries and not here because Pfizer knows it doesn't work.
-PJ
I wonder how long until there’s a good vaccine not based on the spike protein.
The gov’t paid for the creation of the Novavax shot, they had better approve it.
I’m still NOT getting vaxxed. EVER. They’ve already peed in that swimming pool and I’ll not put a toe in it. I’ll stick with my Ivm, Hcq, Zinc & vitamin D, thank you very much.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.